相关实验视频

Updated: Jan 14, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

针对肝细胞癌的新型治疗方法

Mohamed I Elsaid¹, Ashish Manne²

¹Division of Biostatistics and Population Health, Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH, USA; Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA; Cancer Control, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

Clinics in liver disease

|October 18, 2025

概括

肝细胞癌 (HCC) 治疗的进展,包括免疫疗法和向疗法,正在改善生存率. 精确瘤学和解决接入障碍标志着个性化HCC护理的新时代.

科学领域:

肝胆道癌症肝胆道癌症
医学瘤学医学瘤学
翻译研究是翻译研究.

背景情况:

先进的肝细胞癌 (HCC) 治疗已经发生了显著的进化.
传统疗法有局限性,需要新的方法.

研究的目的:

审查先进的HCC中最近的治疗进展.
突出新兴目标和精准医学策略.
强调公平获得护理的重要性.

主要方法:

最近临床试验和研究结果的文献综述.
对新型免疫疗法组合和向药物的分析.
探索精确瘤学工具,如液体活检和AI成像.

主要成果:

免疫疗法组合 (阿特佐利祖马布-贝瓦齐祖马布,伊皮利穆马布-尼沃卢马布,STRIDE) 改善了生存率.
新的检查点 (LAG-3,TIGIT,TIM-3) 和向治疗 (FGFR4,β-catenin) 是有前途的.
代谢途径抑制剂 (ferroptosis,GLS1,NRF2,YAP-TAZ) 显示出协同作用的潜力.

结论:

晚期HCC的治疗场景正在迅速转变.
个性化和有针对性的方法正在成为护理的标准.
确保HCC治疗获得的全球公平性至关重要.

关键词:

抑制FGFR4的发生.铁灭症的诱导作用免疫治疗是一种免疫疗法.液体活检液体活检下一代检查点抑制剂精确瘤学是一门精确的专业.在β-catenin调制过程中.

更多相关视频

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...